BAYER PHARMA AKTIENGESELLSHAFT

City:

Berlin

Country:

Germany

Published Applications:

Last publication date:

2015-07-23

Patent Grants:

Last grant date:

2018-02-13

Top Inventors for applications by BAYER PHARMA AKTIENGESELLSHAFT

These are the the leading inventors for applications assigned to BAYER PHARMA AKTIENGESELLSHAFT:

Joachim KUHNKE 1 Potsdam, Germany
Norbert Schmees 1 Berlin, Germany
Arwed Cleve 1 Berlin, Germany
Chantal Fürstner 1 Muelheim/Ruhr, Germany

Ingo Flamme 1 Reichshof, Germany
Elisabeth Pook 1 Wuppertal, Germany
Matthias Busemann 1 Berlin, Germany
Heinrich Meier 1 Wuppertal, Germany

Stefan Bäurle 1 Berlin, Germany
Carsten Schmeck 1 Mulheim, Germany
Stephan Siegel 1 Berlin, Germany
Dirk Schneider 1 Wuppertal, Germany

Simon Holton 1 Berlin, Germany
Eckhard Bender 1 Langenfeld, Germany
Verena Voehringer 1 Wuppertal, Germany
Bernard Haendler 1 Berlin, Germany

Sabine Krause 1 Berlin, Germany
Amaury Ernesto Fernandez-Montalvan 1 Berlin, Germany
Amaury Ernesto Fernandiez-Montalvan 1 Berlin, Germany
Peter Kolkhof 1 Wuppertal, Germany

Jörg Keldenich 1 Wuppertal, Germany
Dieter Lang 1 Velbert, Germany
Daniel Meibom 1 Leverkusen, Germany
Dagmar Karthaus 1 Solingen, Germany

Ulf Brüggemeier 1 Leichlingen, Germany
Ursula Mönning 1 Woltersdorf, Germany
Pascale Lejeune 1 Berlin, Germany

Recent patent applications by BAYER PHARMA AKTIENGESELLSHAFT

BAYER PHARMA AKTIENGESELLSHAFT based in Berlin, DE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2015-07-23 ✅ Patent 9,890,147 granted on 2018-02-13

US20150203483A1

Chemistry; metallurgy

2,3-benzodiazepines

#2 | 2013-01-03

US20130005704A1

Chemistry; metallurgy

SUBSTITUTED ARYLIMIDAZOLONE AND TRIAZOLONE AS INHIBITORS OF VASOPRESSIN RECEPTORS

AssigneeID:

1925 ⎘